Real-World Evidence and Longitudinal Patient Records-Driven Algorithm Delivers Actionable, AI-Powered Insights at the Point of Care
Atropos Health and Novartis are collaborating to improve the diagnosis of Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare blood disorder, by building, training, and evaluating multiple models to find undiagnosed patients. The collaboration aims to significantly shorten the time from symptom onset to diagnosis and treatment, improving patient experiences and outcomes. The initial AI model, trained on high-quality real-world data from the Atropos Evidence® Network, will be integrated into health systems to help providers identify potential PNH cases more quickly. This initiative represents a significant step forward in using AI and real-world evidence to advance precision medicine and deliver meaningful results for patients.